TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Rezolute ( (RZLT) ) is now available.
Rezolute, Inc. held its 2026 annual meeting of stockholders on November 19, 2025, where a quorum was present with 66,700,068 shares represented. Key outcomes included the election of directors, ratification of Grant Thornton LLP as the independent accounting firm, approval of executive compensation, and an amendment to the 2021 Stock Incentive Plan to increase available shares. Additionally, an adjournment proposal was authorized to solicit more proxies if needed.
The most recent analyst rating on (RZLT) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Rezolute stock, see the RZLT Stock Forecast page.
Spark’s Take on RZLT Stock
According to Spark, TipRanks’ AI Analyst, RZLT is a Neutral.
Rezolute’s overall stock score is impacted by its challenging financial performance, with persistent losses and operational inefficiencies. However, technical analysis shows moderate upward momentum, and positive corporate events, including significant funding and promising clinical trial progress, offer potential upside. Valuation remains weak with negative earnings, suggesting cautious optimism for the stock’s future.
To see Spark’s full report on RZLT stock, click here.
More about Rezolute
Average Trading Volume: 1,428,994
Technical Sentiment Signal: Hold
Current Market Cap: $942.1M
For detailed information about RZLT stock, go to TipRanks’ Stock Analysis page.